Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy

Catherine Vignal, Scott Uretsky, Serge Fitoussi, Anne Galy, Laure Blouin, Jean François Girmens, Samuel Bidot, Nitza Thomasson, Céline Bouquet, Sonia Valero, Sandrine Meunier, Jean Philippe Combal, Bernard Gilly, Barrett Katz, José Alain Sahel

Research output: Contribution to journalArticle

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)945-947
Number of pages3
JournalOphthalmology
Volume125
Issue number6
DOIs
StatePublished - Jun 2018

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Vignal, C., Uretsky, S., Fitoussi, S., Galy, A., Blouin, L., Girmens, J. F., Bidot, S., Thomasson, N., Bouquet, C., Valero, S., Meunier, S., Combal, J. P., Gilly, B., Katz, B., & Sahel, J. A. (2018). Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy. Ophthalmology, 125(6), 945-947. https://doi.org/10.1016/j.ophtha.2017.12.036